Wisconsin Administrative Code (Last Updated: January 10, 2017) |
Agency CSB. Controlled Substances Board |
Chapter 2. Additions To Schedules In SS. 961.14, 961.16, 961.18, 961.20 And 961.22, Stats. |
Section 2.17. Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II.
Latest version.
- (2) Paragraph (b) of s. 161.14 (5), Stats. , is adopted to read:(b) Methaqualone(3) Subsection (7) (am) of s. 161.16, Stats., is repealed.(4) Subsection (10) (a) of s. 161.16, Stats. , is created to read:(10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)
Cr.
Register, August, 1986, No. 368
, eff. 9-1-86;
CR 03-056
: r. (1)
Register January 2004 No. 577
, eff. 2-1-04.